Jason discusses the erosion of trust in large consumable companies, attributing it to a focus on shareholder value over human health. He highlights the shift towards synthetic ingredients and the negative impact on consumer perception. As awareness grows, Jason emphasizes the need for larger companies to regain trust and improve health outcomes, advocating for a new approach that prioritizes both quality and consumer well-being.
